Search -

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News EuroPCR 2022

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

Caitlin E. Cox

May 25, 2022

News Conference News EuroPCR 2022

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Yael L. Maxwell

May 17, 2022

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Conference News EAS 2021

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Michael O'Riordan

June 08, 2021

News Conference News SCAI 2021

Chinese Registry Supports Prolonged DAPT Following PCI for ACS

Yael L. Maxwell

May 03, 2021

News Daily News

New Tool Helps Balance Bleeding and Thrombotic Risks After PCI

Yael L. Maxwell

January 13, 2021

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Industry News

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

June 01, 2020

Presentation JIM 2020

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Presenter: Marco Valgimigli

February 13, 2020

News Conference News EuroPCR 2019

New Clarity on Patients at High Risk for Bleeding After PCI

Michael O'Riordan

May 28, 2019

News Industry News

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

October 30, 2016

CME

Advertisement

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Chinese Registry Supports Prolonged DAPT Following PCI for ACS

New Tool Helps Balance Bleeding and Thrombotic Risks After PCI

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

New Clarity on Patients at High Risk for Bleeding After PCI

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

Updates on Onyx ONE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content